« Previous
Next »
Leukemia Research
Volume 26, Issue 10
, Pages 899-902
, October 2002
Less apoptosis in patients with 5q-syndrome than in patients with refractory anemia
References
-
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman, J, et al. In: Proceedings of The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting. Airlie House, VA, November 1997. Mod. Pathol. 2000;13:193–207.
- . The 5q-anomaly. Cancer Genet. Cytogenet. 1985;17:189–255
-
.
Specificity of haematological indicators for 5q-syndrome in patients with myelodysplastic syndromes.
Euro J. Haemat. 1987;39:326–330
-
.
5q as a sole chromosome abnormality in myelodysplastic syndromes and acute myeloid leukemia (Abstract).
Mod. Pathol. 2001;14:182A
- Excessive proliferation matched by excessive apoptosis in myelodysplastic syndromes: the cause–effect relationship. Leuk. Lymphoma. 1997;27:111–118
- . Apoptotic index by annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes. Cytometry. 2001;46:28–32
- . A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 1993;197:40–45
- . B cell receptor-stimulated mitochondrial phospholipase A2 activation and resultant disruption of mitochondrial membrane potential correlate with the induction of apoptosis in WEHI-231 B cells. J. Immunol. 2001;166:137–147
- . A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 1993;197(1):40–45
PII: S0145-2126(02)00039-5
© 2002 Elsevier Science Ltd. All rights reserved.
« Previous
Next »
Leukemia Research
Volume 26, Issue 10
, Pages 899-902
, October 2002
